• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种预测接受抗逆转录病毒治疗后HIV感染者高体重指数的模型。

A model for predicting high BMI of people living with HIV after receiving antiretroviral therapy.

作者信息

Qian Zhe, Wu Houji, Wu Yihua, Liao Wei, Yu Tao, Xu Xuwen, Peng Jie, Cai Shaohang

机构信息

Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, China.

Intensive Care Unit, Sun Yat-sen University Cancer Center, Guangzhou, China.

出版信息

Ther Adv Chronic Dis. 2022 Jun 21;13:20406223221102750. doi: 10.1177/20406223221102750. eCollection 2022.

DOI:10.1177/20406223221102750
PMID:35757780
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9218435/
Abstract

OBJECTIVE

The objective of this study was to evaluate the characteristics of high body mass index (BMI) and normal weight people living with HIV after antiretroviral therapy (ART) and establish a model.

METHODS

A total of 290 people living with HIV after 1 year of ART treatment were enrolled and divided into two groups based on whether their BMI index was <24 or ⩾24 at week 48. The demographic, clinical data were collected and analyzed. Multivariable logistic regression analysis was performed. A model was established and use to predict the occurrence of certain diseases.

RESULTS

A total of 290 people living with HIV were included in this study; 200 had a normal BMI (BMI < 24) and 90 were high BMI (BMI ⩾ 24) after 1-year ART. Their baseline characteristics were significantly different in relation to age ( = 0.007), sex distribution ( = 0.040), ART regimen ( = 0.040), alanine aminotransferase levels ( < 0.001), and three major serum lipid levels: triglycerides ( < 0.001), cholesterol ( = 0.011), and low-density lipoprotein ( = 0.005). A multivariate logistic regression analysis resulted in the development of a model for the diagnosis of high BMI and hyperlipidemia. The model score is an independent risk factor for hyperlipidemia (odds ratio = 2.674,  = 0.001) and high BMI ( < 0.001). The model score is significantly correlated with the controlled attenuation parameter (CAP) value ( = 0.230,  < 0.001) and can be used to divide the severity of liver steatosis based on CAP value.

CONCLUSIONS

This study demonstrated a easy-to-use model to detect high BMI, hyperlipidemia, and liver steatosis in people living with HIV without risk factors for BMI changing at baseline after 1 year of ART treatment.

摘要

目的

本研究的目的是评估接受抗逆转录病毒治疗(ART)后体重指数(BMI)高和体重正常的HIV感染者的特征,并建立一个模型。

方法

共纳入290例接受ART治疗1年的HIV感染者,根据其在第48周时的BMI指数是<24还是⩾24分为两组。收集并分析人口统计学、临床数据。进行多变量逻辑回归分析。建立一个模型并用于预测某些疾病的发生。

结果

本研究共纳入290例HIV感染者;1年ART治疗后,200例BMI正常(BMI<24),90例BMI高(BMI⩾24)。他们的基线特征在年龄(P=0.007)、性别分布(P=0.040)、ART方案(P=0.040)、丙氨酸转氨酶水平(P<0.001)以及三项主要血脂水平:甘油三酯(P<0.001)、胆固醇(P=0.011)和低密度脂蛋白(P=0.005)方面存在显著差异。多变量逻辑回归分析得出了一个用于诊断高BMI和高脂血症的模型。模型得分是高脂血症(比值比=2.674,P=0.001)和高BMI(P<0.001)的独立危险因素。模型得分与受控衰减参数(CAP)值显著相关(P=0.230,P<0.001),可用于根据CAP值划分肝脂肪变性的严重程度。

结论

本研究展示了一个易于使用的模型,可在无BMI基线变化危险因素的HIV感染者接受1年ART治疗后检测高BMI、高脂血症和肝脂肪变性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9805/9218435/9058178540a0/10.1177_20406223221102750-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9805/9218435/5127f03f4070/10.1177_20406223221102750-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9805/9218435/e809e0f42cb0/10.1177_20406223221102750-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9805/9218435/9058178540a0/10.1177_20406223221102750-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9805/9218435/5127f03f4070/10.1177_20406223221102750-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9805/9218435/e809e0f42cb0/10.1177_20406223221102750-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9805/9218435/9058178540a0/10.1177_20406223221102750-fig3.jpg

相似文献

1
A model for predicting high BMI of people living with HIV after receiving antiretroviral therapy.一种预测接受抗逆转录病毒治疗后HIV感染者高体重指数的模型。
Ther Adv Chronic Dis. 2022 Jun 21;13:20406223221102750. doi: 10.1177/20406223221102750. eCollection 2022.
2
Stratifying the risk of NAFLD in patients with HIV under combination antiretroviral therapy (cART).在接受联合抗逆转录病毒疗法(cART)的HIV患者中对非酒精性脂肪性肝病(NAFLD)风险进行分层。
EClinicalMedicine. 2021 Sep 5;40:101116. doi: 10.1016/j.eclinm.2021.101116. eCollection 2021 Oct.
3
Hepatic steatosis in individuals living with HIV measured by controlled attenuation parameter: a cross-sectional study.通过受控衰减参数测量的HIV感染者的肝脂肪变性:一项横断面研究。
Eur J Gastroenterol Hepatol. 2015 Jun;27(6):679-85. doi: 10.1097/MEG.0000000000000339.
4
Prevalence and predicting factors of metabolic-associated fatty liver disease diagnosed by transient elastography with controlled attenuation parameters in HIV-positive people.基于受控衰减参数的瞬时弹性成像技术诊断 HIV 阳性人群代谢相关脂肪性肝病的流行情况及其影响因素。
Int J STD AIDS. 2021 Mar;32(3):266-275. doi: 10.1177/0956462420960997. Epub 2020 Dec 18.
5
Prevalence and Predictors of Hepatic Steatosis in Patients with HIV/HCV Coinfection and the Impact of HCV Eradication.HIV/HCV 合并感染患者肝脂肪变性的流行情况及预测因素,以及 HCV 清除的影响。
AIDS Patient Care STDS. 2019 May;33(5):197-206. doi: 10.1089/apc.2018.0333.
6
[Correlation between neutrophil/lymphocyte ratio combined with low-density lipoprotein cholesterol/high-density lipoprotein cholesterol ratio and severity of coronary artery disease in patients with acute coronary syndrome].[中性粒细胞/淋巴细胞比值联合低密度脂蛋白胆固醇/高密度脂蛋白胆固醇比值与急性冠状动脉综合征患者冠状动脉疾病严重程度的相关性]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2022 Mar;34(3):274-279. doi: 10.3760/cma.j.cn121430-20211008-01441.
7
Treatment with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children is associated with a sustained effect on growth.对感染1型人类免疫缺陷病毒的儿童采用高效抗逆转录病毒疗法进行治疗,与对生长的持续影响相关。
Pediatrics. 2002 Feb;109(2):E25. doi: 10.1542/peds.109.2.e25.
8
Antiretroviral Therapy Anchor-based Trends in Body Mass Index Following Treatment Initiation Among Military Personnel with HIV.抗逆转录病毒疗法:基于治疗起始时体重指数的 HIV 感染者治疗后趋势。
Mil Med. 2021 Feb 26;186(3-4):279-285. doi: 10.1093/milmed/usaa416.
9
First-line antiretroviral therapy and dyslipidemia in people living with HIV-1 in Cameroon: a cross-sectional study.喀麦隆艾滋病毒 1 型感染者的一线抗逆转录病毒治疗与血脂异常:一项横断面研究。
AIDS Res Ther. 2011 Sep 26;8:33. doi: 10.1186/1742-6405-8-33.
10
Diagnostic Accuracy of Controlled Attenuation Parameter for Detecting Hepatic Steatosis in Patients with Chronic Liver Disease.受控衰减参数检测慢性肝病患者肝脂肪变性的诊断准确性
GE Port J Gastroenterol. 2017 Jul;24(4):161-168. doi: 10.1159/000453364. Epub 2016 Dec 23.

引用本文的文献

1
Inflammation markers and the risk of hypertension in people living with HIV.炎症标志物与 HIV 感染者患高血压的风险。
Front Immunol. 2023 Mar 21;14:1133640. doi: 10.3389/fimmu.2023.1133640. eCollection 2023.

本文引用的文献

1
Weight changes after antiretroviral therapy initiation in CoRIS (Spain): a prospective multicentre cohort study.抗逆转录病毒治疗启动后 CoRIS(西班牙)的体重变化:一项前瞻性多中心队列研究。
J Int AIDS Soc. 2021 May;24(5):e25732. doi: 10.1002/jia2.25732.
2
NASH in HIV.非酒精性脂肪性肝炎(NASH)合并 HIV 感染。
Curr HIV/AIDS Rep. 2020 Dec;17(6):601-614. doi: 10.1007/s11904-020-00531-0.
3
Reckoning with mortality: global health, HIV, and the politics of data.直面死亡率:全球健康、艾滋病病毒与数据政治
Lancet. 2020 Jul 25;396(10246):288-290. doi: 10.1016/S0140-6736(20)31046-1. Epub 2020 Jul 3.
4
Obesity and Weight Gain in Persons with HIV.肥胖和 HIV 感染者体重增加。
Curr HIV/AIDS Rep. 2020 Apr;17(2):138-150. doi: 10.1007/s11904-020-00483-5.
5
A gathering storm: HIV infection and nonalcoholic fatty liver disease in low and middle-income countries.蓄势待发的风暴:中低收入国家的 HIV 感染与非酒精性脂肪性肝病。
AIDS. 2019 Jun 1;33(7):1105-1115. doi: 10.1097/QAD.0000000000002161.
6
Coronary Artery Disease Manifestations in HIV: What, How, and Why.HIV 相关冠状动脉疾病的表现:是什么、如何表现、为什么。
Can J Cardiol. 2019 Mar;35(3):270-279. doi: 10.1016/j.cjca.2018.11.029. Epub 2018 Dec 4.
7
Epidemiological analyses of regional and age differences of HIV/AIDS prevalence in China, 2004-2016.中国 2004-2016 年 HIV/AIDS 流行的地区和年龄差异的流行病学分析。
Int J Infect Dis. 2019 Apr;81:215-220. doi: 10.1016/j.ijid.2019.02.016. Epub 2019 Feb 20.
8
HIV.艾滋病病毒。
Lancet. 2018 Aug 25;392(10148):685-697. doi: 10.1016/S0140-6736(18)31311-4. Epub 2018 Jul 23.
9
Higher Risk of Abdominal Obesity, Elevated Low-Density Lipoprotein Cholesterol, and Hypertriglyceridemia, but not of Hypertension, in People Living With Human Immunodeficiency Virus (HIV): Results From the Copenhagen Comorbidity in HIV Infection Study.与人类免疫缺陷病毒(HIV)感染者共存的人群,其腹部肥胖、低密度脂蛋白胆固醇升高和高三酰甘油血症的风险更高,但高血压的风险没有增加:来自哥本哈根 HIV 感染合并症研究的结果。
Clin Infect Dis. 2018 Aug 1;67(4):579-586. doi: 10.1093/cid/ciy146.
10
Metabolic syndrome and obesity are the cornerstones of liver fibrosis in HIV-monoinfected patients.代谢综合征和肥胖是 HIV 单感染患者肝纤维化的基石。
AIDS. 2017 Sep 10;31(14):1955-1964. doi: 10.1097/QAD.0000000000001587.